Coriolus versicolor

Integrative Medicine
Developing Your Personal Care Plan
Integrative Medicine at Home Membership Program
Therapies, Classes & Workshops
About Herbs, Botanicals & Other Products
About Mind-Body Therapies
Our Research & Clinical Trials
Multimedia

Coriolus versicolor

Share
Share
Coriolus Versicolor

Common Names

  • PSK
  • PSP
  • VPS
  • Turkey Tail
  • Yun Zhi
  • Kawaratake
  • Krestin

Jump to:

For Patients & Caregivers

Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.

What is it?

Coriolus is a mushroom used to help with health issues in traditional Chinese medicine. It also comes as dietary supplements in pills or powders.

What is it used for?

Coriolus is used to:

  • Improve general health
  • Treat cancer
  • Boost the immune system

Coriolus also has other uses that haven’t been studied by doctors to see if they work.

It’s generally safe to use coriolus in food and tea, but talk with your healthcare providers before taking coriolus supplements. Herbal supplements are stronger than the herbs you would use in cooking.

They can also interact with some medications and affect how they work. For more information, read the “What else do I need to know?” section below.

What are the side effects?

Side effects of using coriolus may include:

  • Dark colored stool (poop)
  • Darkening of fingernails
What else do I need to know?
  • Talk to your healthcare provider before taking coriolus in any form if you’re pregnant or breastfeeding. It is not known if this mushroom is safe.
Back to top

For Healthcare Professionals

Brand Name
Krestin
Scientific Name
Coriolus versicolor, Trametes versicolor, Polyporus versicolor, Polystictus versicolor
Clinical Summary

Coriolus versicolor is a mushroom of the Basidiomycetes class. It is used in traditional Chinese medicine as a tonic, and studies suggest that it has immunostimulant and antitumor properties. Polysaccharide-K (PSK), a proprietary product derived from Coriolus, was developed for cancer treatment in Japan. Other Coriolus extracts such as polysaccharide-peptide (PSP) and VPS are available as dietary supplements.

When used as an adjuvant, PSK appears to improve survival rates in patients with gastric (1) (2) and colorectal (3) (4) (5) cancers. It may also benefit patients with esophageal cancer (27). Findings from a study of PSP in conjunction with chemotherapy suggest benefits in patients with advanced non-small cell lung cancer (6). PSP was also reported to act as a prebiotic and to modulate human intestinal microbiome composition (30). Studies of Coriolus extracts alone or in combination with other botanicals suggest positive immunomodulatory effects (7) (8). However, data on their effects on breast cancer (9), hepatocellular carcinoma (10) (28), or leukemia (11) are mixed. A meta-analysis reported reduced mortality risk with adjuvant use of Coriolus across a variety of cancers (29), but confirmatory studies are needed.

In an open-label randomized trial, use of a Coriolus–based vaginal gel had clinical benefit over watchful waiting for patients with HPV-related low-grade cervical lesions (31).

Coriolus extracts are generally well tolerated but minor adverse effects have been reported. Many over-the-counter products are not standardized, making it difficult to compare potency between brands. It is also unclear if PSK, PSP, and other Coriolus extracts have comparable effects.

Purported Uses
  • Health maintenance
  • Cancer treatment
  • Immunomodulation
Mechanism of Action

Coriolus versicolor is thought to be a biological response modifier. In vitro, PSP, PSK, and Coriolus extract induces apoptosis in leukemia cells (13) (23) (24). PSP also increased apoptosis in cells treated with camptothecin, reduced proliferation, progression, and 3H-thymidine uptake, and prolonged DNA synthesis time (14). A Coriolus medicinal mushroom blend inhibited cell proliferation and induced G2/M cell cycle arrest in an invasive breast cancer cell line (15). The mushroom extract inhibits expression of cell-cycle regulatory genes and suppresses metastatic behavior via inhibition of cell adhesion, migration, and invasion. Antiproliferative effects were linked to suppression of urokinase plasminogen activator (15). PSP also inhibits interaction between HIV-1 gp120 and CD4 receptor, HIV-1 transcriptase activity, and glycohydrolase enzyme activity associated with viral glycosylation (16).

Several animal studies report synergy between PSK and biologic therapies, including a concanavalin A-bound L1210 vaccine and the IgG2a monoclonal antibody against human colon cancer cells (17). PSP induces cytokine production and T-cell proliferation, and prevents cyclophosphamide-induced immune suppression. Peritoneal macrophages isolated from PSP-fed mice show increased production of reactive nitrogen intermediates, superoxide anions, and TNF (18). PSP also shows analgesic activity in mouse models (19).

In human studies, non-small cell lung cancer patients have increased leukocyte and neutrophil counts after PSP consumption, as well as increased serum IgG and IgM (6). Healthy volunteers and breast cancer patients who used a formula containing Coriolus and Salvia had elevated CD4+ counts, a high CD4+/CD8+ ratio, and elevated absolute counts of B-lymphocytes (7) (8). TNF-alpha and IL-8 gene expression were significantly induced after PSK administration in healthy volunteers and gastric cancer patients, although individual response varied (20).

High doses of a hot water extract of Coriolus enhanced development of large intestinal tumors in mice (12). However, this is not clinically relevant as the dosage was 10-13x higher than what is used in human studies and the mice were injected with known potent carcinogens.

Contraindications
  • Until safety data become available, pregnant or breastfeeding women should avoid taking Coriolus.
Adverse Reactions

Rare: Dark colored stools not originating from occult blood (21), darkening of fingernails (22), and low-grade hematological and gastrointestinal toxicities when used in conjunction with chemotherapy (3). However, such effects may be caused by the chemotherapy agents themselves.

Dosage (OneMSK Only)
References
  1. Nakazato H, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994; 343(8906): 1122-6.
  2. Niimoto M, et al. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg 1988; 18(6): 681-6.
  3. Ohwada S, et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer 2004; 90(5): 1003-10.
  4. Mitomi T, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum 1992; 35(2): 123-30.
  5. Torisu M, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990; 31(5): 261-8.
  6. Tsang KW, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 2003; 97(6): 618-24.
  7. Wong CK, et al. Immunomodulatory effects of yun zhi and danshen capsules in health subjects—a randomized, double-blind, placebo-controlled, crossover study. Int Immunopharmacol 2004; 4(2): 201-11.
  8. Wong CK, et al. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005; 33(3): 381-95.
  9. Iino Y, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995; 15(6B): 2907-11.
  10. Suto T, et al. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33: S145-8.
  11. Ohno R, et al. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunol Immunother 1984; 18(3): 149-54.
  12. Toth B, Coles M, Lynch J. Effects of VPS extract of Coriolus versicolor on cancer of the large interstine using a serial sacrifice technique. In Vivo 2006;20(3):341-6.
  13. Yang X, et al. The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. Oncol Rep 2005; 13(6): 1201-10.
  14. Wan JMF, Sit WH, Yang X, Jiang P, Wong LY. Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells. Chinese Medicine. 2010;5:16.
  15. Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 2010 Dec;37(6):1529-36.
  16. Collins RA, Ng TB. Polysaccharopeptide from Coriolus versicolor has Potential for Use Against Human Immunodeficiency Virus type I Infection. Pharmcology Letters 1997; 60(25): 387-387.
  17. Tsukagoshi S, et al. Krestin (PSK). Cancer Treat Rev 1984; 11(2): 131-55.
  18. Liu WK, et al. Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor. Immunopharmacology 1993; 26(2): 139-46.
  19. Ng TB, Chan WY. Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice. Gen Pharmacol 1997; 29(2): 269-73.
  20. Kato M, et al. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother 1995; 40(3): 152-6.
  21. Shiu WCT, et al. A Clinical Study of PSP on Peripheral Blood Counts during Chemotherapy. Phytotherapy Research 1992; (6): 217-218.
  22. Kidd, PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000 5(1): 4-27.
  23. Lau CB, et al. Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis. Life Sci 2004; 75(7): 797-808.
  24. Hirahara N, Edamatsu T, Fujieda A, et al. Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells. Anticancer Res. 2012 Jul;32(7):2631-7.
  25. Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002 May-Jun;22(3):1737-54.
  26. Cui J, Chisti Y. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv. 2003 Apr;21(2):109-22.
  27. Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. Am J Clin Oncol. 1995 Jun;18(3):216-22.
  28. Chay WY, Tham CK, Toh HC, et al. Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy. J Altern Complement Med. Aug 2017;23(8):648-652.
  29. Zhong L, Yan P, Lam WC, et al. Coriolus versicolor and Ganoderma lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2019;10:703.
  30. Pallav K, Dowd SE, Villafuerte J, et al. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial. Gut Microbes. 2014 Jul 1;5(4):458-67.
  31. Serrano L, López AC, González SP, et al. Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study. J Low Genit Tract Dis. Apr 1 2021;25(2):130-136.
Back to top
Back to top
Email your questions and comments to [email protected].

Last Updated